Your browser doesn't support javascript.
loading
The new paradigm of systemic therapies for metastatic melanoma.
Volpe, Virginia O; Klufas, Daniel M; Hegde, Upendra; Grant-Kels, Jane M.
Afiliação
  • Volpe VO; Department of Internal Medicine, Division of Oncology's Neag Cancer Center, University of Connecticut Health Center, Farmington, Connecticut.
  • Klufas DM; Department of Dermatology, University of Connecticut Health Center, Farmington, Connecticut.
  • Hegde U; Department of Internal Medicine, Division of Oncology's Neag Cancer Center, University of Connecticut Health Center, Farmington, Connecticut.
  • Grant-Kels JM; Department of Dermatology, University of Connecticut Health Center, Farmington, Connecticut. Electronic address: grant@uchc.edu.
J Am Acad Dermatol ; 77(2): 356-368, 2017 Aug.
Article em En | MEDLINE | ID: mdl-28711086

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Inibidores de Proteínas Quinases / Fatores Imunológicos / Melanoma / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Inibidores de Proteínas Quinases / Fatores Imunológicos / Melanoma / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article